Dr. Frank Hensel
Principal
About me
| Team | Life Sciences & Chemistry |
| at HTGF since | 2015 |
| my focus | Drug development |
| my background | PhD in biology, founder of a biotech company |
CV
Dr Frank Hensel holds a PH.D. in biology and has a longstanding experience as Entrepreneur in a Start-Up developing human monoclonal antibodies for cancer treatment. Since being part of HTGF in 2015 Frank built a solid portfolio of start-ups with a focus on drug development companies. Out of this portfolio 3 companies already entered the clinical stage and one company, Amal therapeutics, was successfully exited to Boehringer Ingelheim with a deal volume of up to 425Mio. €
Four questions for …
What has been your most important milestone so far?
Having founded a startup myself and having gone through all the ups and downs with it over years.
What fascinates you about pre-seed/seed phases?
You can still move and structure a lot in the seed sector. No two cases are the same and every investment is a new challenge.
What do you like most about your job?
Interaction with great scientists and interesting technologies that can be provided to patients through collaboration with investors.
What inspires you outside of work?
A few hours on the racing bike clear your head and give you time to think.